Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > td have someone who dont wanna be squezzed

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Oct 02, 2018 10:37am

68 Views

Post# 28728591

RE:td have someone who dont wanna be squezzed

The news wasn’t fantastic -
—no meantion of funding
-no mention of joint venture
-no mentions of potential partners
-no mention of prospectus status
-no mention of anything important

all it seems lile
is they are really hoping that imnp pays them a bit of money and that may not be until feb March

this is why the stock tick isn’t moving....this is why I sold out at 11.5 cents
this will be back at 10-10.5 before it passes 13

<< Previous

Bullboard Posts

Next >>

Dynamic Funds Launches new ETF series on the TSX